RIA: A new Opportunity for Medical Isotope Research and Production



Similar documents
DEMONSTRATION ACCELERATOR DRIVEN COMPLEX FOR EFFECTIVE INCINERATION OF 99 Tc AND 129 I

Status of High Current Ion Sources. Daniela Leitner Lawrence Berkeley National Laboratory

The Californium Source Upgrade

Nuclear Medicine & PET Research. F Production. Radiochemie.nl Cursus 18 F chemie

Isotope Separation On Line and Post Acceleration

Chemistry CP Unit 2 Atomic Structure and Electron Configuration. Learning Targets (Your exam at the end of Unit 2 will assess the following:)

Chem 115 POGIL Worksheet - Week 4 Moles & Stoichiometry

Technical Meeting on the Socio-Economic Benefits of Ion Beam Accelerators for Developing Member States

Chem 115 POGIL Worksheet - Week 4 Moles & Stoichiometry Answers

Development of Radiation Resistant Quadrupoles Based on High Temperature Superconductors for the Fragment Separator

Seminar 7. Medical application of radioisotopes - radiotherapy

M. Marengo. Medical Physics Department University Hospital S.Orsola Malpighi, Bologna

The Mole. Chapter 2. Solutions for Practice Problems

Bert Windhorst Radiopharmaceutical scientist VU University Medical Center Amsterdam

THE ALIGNMENT STRATEGY FOR THE SPIRAL2 SUPERCONDUCTING LINAC CRYOMODULES

Noble Gases. Outline Nobel Gas Elements Radon and Health Chemistry Homework

Radioactivity III: Measurement of Half Life.

Vacuum Evaporation Recap

Current Engineering and Design Activities at Los Alamos National Laboratory Supporting Commercial U.S. Production of 99Mo without the Use of HEU

B I N G O B I N G O. Hf Cd Na Nb Lr. I Fl Fr Mo Si. Ho Bi Ce Eu Ac. Md Co P Pa Tc. Uut Rh K N. Sb At Md H. Bh Cm H Bi Es. Mo Uus Lu P F.

University of Missouri and MU Research Reactor Center

IBA Proton Therapy. Biomed days Vincent Bossier. System Architect Protect, Enhance and Save Lives

ACCELERATORS AND MEDICAL PHYSICS 2

P O L Y T E C R.M. S.R.L.

COST / BENEFIT COMPARISON 45 MEV AND 70 MEV CYCLOTRONS MAY 26, 2005 FOR

Nuclear Fusion and Radiation

Objectives 404 CHAPTER 9 RADIATION

Chemistry - Elements Electron Configurations The Periodic Table. Ron Robertson

Medical Applications of radiation physics. Riccardo Faccini Universita di Roma La Sapienza

K O M A C. Beam Commissioning of 100-MeV KOMAC Linac. Korea Multi-purpose Accelerator Complex 양 성 자 가 속 기 연 구 센 터

Study of electron cloud at MI and slip stacking process simulation

MSU View of RIA R&D Priorities. R.C. York August 2003

Crystal Structure of Aluminum, Zinc, and their Alloys By: Omar Fajardo Sebastian Henao Devin Baines ENGR45, F2014, SRJC

Principles of Ion Implant

MYRRHA Injector Design

All answers must use the correct number of significant figures, and must show units!

4. CHEMICAL, PHYSICAL, AND RADIOLOGICAL INFORMATION

47374_04_p25-32.qxd 2/9/07 7:50 AM Page Atoms and Elements

Gamma Ray Detection at RIA

Centro Radiológico de Aplicações Protônicas

HIGH CURRENT OPERATION OF THE ACSI TR30 CYCLOTRON

Chapter 2 Atoms, Ions, and the Periodic Table

Activities at the University of Frankfurt (IAP)

NUCLEAR SERVICES & TECHNOLOGY

Name period AP chemistry Unit 2 worksheet Practice problems

Nuclear Physics. Nuclear Physics comprises the study of:

HITACHI Proton Beam Therapy System

2 ATOMIC SYSTEMATICS AND NUCLEAR STRUCTURE

Chemical Sputtering. von Kohlenstoff durch Wasserstoff. W. Jacob

Mars Atmosphere and Volatile EvolutioN (MAVEN) Mission

Modification of Pd-H 2 and Pd-D 2 thin films processed by He-Ne laser

Reliability and Availability Aspects of. the IPHI Project

THORIUM UTILIZATION FOR SUSTAINABLE SUPPLY OF NUCLEAR ENERGY S. BANERJEE DEPARTMENT OF ATOMIC ENERGY

CHEM 1411 Chapter 5 Homework Answers

For convenience, we may consider an atom in two parts: the nucleus and the electrons.

Cancer Therapy with Particle Beams

Fuel Cell Activities at TU Graz

CH3 Stoichiometry. The violent chemical reaction of bromine and phosphorus. P.76

Running in Luminosity. Mike Lamont Verena Kain

Cyclotron Centre in Poland and 2D thermoluminescence dosimetry

The Wilson Chamber. Karlsruhe, Fall 2002

Electrical tests on PCB insulation materials and investigation of influence of solder fillets geometry on partial discharge

SECTION 15: Nuclear Reactions

Chapter 8. Low energy ion scattering study of Fe 4 N on Cu(100)

Solid State Detectors = Semi-Conductor based Detectors

RADIOISOTOPES in MEDICINE:

Write an equation, including state symbols, for the ionisation of indium that requires the minimum energy.(1)

Sputtering by Particle Bombardment I

STUDY OF THE TRANSVERSE BEAM EMITTANCE OF THE BERN MEDICAL CYCLOTRON

Success criteria You should be able to write the correct formula for any ionic compound

Overview of Proton Beam Cancer Therapy with Basic Economic Considerations

Nanometer-scale imaging and metrology, nano-fabrication with the Orion Helium Ion Microscope

INFO-0545 RADIOISOTOPE SAFETY MONITORING FOR RADIOACTIVE CONTAMINATION

Turnkey Solutions for Radiation Protection in PET Laboratories R A D I A T I O N P R O T E C T I O N

The content is based on the National Science Teachers Association (NSTA) standards and is aligned with state standards.

2. John Dalton did his research work in which of the following countries? a. France b. Greece c. Russia d. England

CLASS TEST GRADE 11. PHYSICAL SCIENCES: CHEMISTRY Test 6: Chemical change

Nuclear ZPE Tapping. Horace Heffner May 2007

RARE ISOTOPE ACCELERATOR (RIA) PROJECT*

h e l p s y o u C O N T R O L

The Advanced Placement Examination in Chemistry. Part I Multiple Choice Questions Part II Free Response Questions Selected Questions from1970 to 2010

ORTEC DET-SW-UPG. Latest Software Features. Ease of Use. Source Location with the Detective V3 Software

EXPERIMENT 4 The Periodic Table - Atoms and Elements

The OPERA Emulsions. Jan Lenkeit. Hamburg Student Seminar, 12 June Institut für Experimentalphysik Forschungsgruppe Neutrinophysik

ABSORPTION OF BETA AND GAMMA RADIATION

Results: Low current ( ) Worst case: 800 MHz, GeV, 4 turns Energy oscillation amplitude 154 MeV, where

neutrons are present?

CORSO DI FISICA NUCLEARE - PAOLO FINELLI DIP. FISICA ED ASTRONOMIA - UNIVERSITÀ DI BOLOGNA

. Tutorial #3 Building Complex Targets

Characterization of excited states of 15 N through 14 C(p,p) 14 C using polarized proton beam

SCH 3UI Unit 2 Outline Up to Quiz #1 Atomic Theory and the Periodic Table

Proton Radiotherapy. Cynthia Keppel Scientific and Technical Director Hampton University Proton Therapy Institute. Lead Virginia.

Chapter 17: Radioactivity and Nuclear Chemistry

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE CHEM COLLEGE CHEMISTRY I

Potassium-Argon (K-Ar) Dating

The Existence of a Neutron

Industrial tracers - Finding leaks and blockages

PFC/JA MIT Fusion 7-Ray Diagnostic Development. K. W. Wenzel, R. D. Petrasso, D. H. Lo, C. K. Li,

Chapter The Nucleus and Radioactivity Uses of Radioactive Substances Nuclear Energy

World-first Proton Pencil Beam Scanning System with FDA Clearance

Transcription:

RIA: A new Opportunity for Medical Isotope Research and Production Jose R. Alonso Fanqing Guo Lawrence Berkeley` National Laboratory J. Alonso 1

Outline Accelerator-based medical isotope production today New opportunities presented by RIA Isotope production using light ions Role of RIA in fostering new opportunities for medical isotope production techniques J. Alonso 2

Current State of the Art H - cyclotrons have revolutionized high-current applications Stripping extraction provides 100% extraction efficiency Greatly reduces activation Reduces thermal loading on extractors Maximum current 500 µa Vendors claim currents up to 1 ma obtainable Typical top energy 50 MeV Lorentz stripping limits highest energies BUT: Limited to z = 1 beam J. Alonso 3

Examples of Current Production 67 Ga Use: Diagnostic imaging via SPECT Halflife: 78 hrs Reaction: 68 Zn (p, 2n) 67 Ga Isotopic abundance of target: 18% Production rate: 4.5 mci/µah Yield 1 Ci/hr 201 Tl Use: Diagnostic imaging, SPECT Halflife: 73 hrs Reaction: 203 Tl (p, 3n) 201 Pb 201 Tl Isotopic abundance of target: 23% Production rate: 1.5 mci/µah Yield 500 mci/hr J. Alonso 4

Examples (cont.) 103 Pd Use: Brachytherapy - seeds implanted for prostate cancer treatment Halflife: 17 days Reaction: 103 Rh (p,n) 103 Pd Isotopic abundance of target: 100% Production rate: 0.5 mci/µah Yield 150 mci/hr J. Alonso 5

Example: 82 Rb- 82 Sr Generator J. Alonso 6

Example: 82 Rb- 82 Sr Generator J. Alonso 7

Example: 82 Rb- 82 Sr Generator J. Alonso 8

Evaluation PET-generators (for instance Strontium- Rubidium) are too cost-expensive. In Germany only one study was performed. Gustav Hör, Frankfurt, Radiopharmacy-Clinical Reality and Selected Research Demands reported in Regional Workshop, Slowak Academy of Sciences, Nov 2001 Issues affecting cost: 60 MeV is beyond range of most commercial H - cyclotrons Yield for {4n} lower than other reactions J. Alonso 9

Proton-based production Very little flexibility available Product must be close to target Z, A Most often requires separated isotope targets May require complex chemistry In marketplace where cost factors are of great importance, this lack of flexibility can be a restricting factor for optimum exploitation of technique J. Alonso 10

RIA Driver For first time, currents of light ions approach levels capable of commercial isotope production Driver Linac can be configured to allow diversion of low-energy beams J. Alonso 11

Light Ions Provide: Alternatives for currently-popular isotopes Flexibility of ion species Flexibility in target selection Several reactions can produce same isotope Possibility of avoiding separated isotopes Target selection to facilitate chemistry Access to many new isotopes E.g. in transuranic region Kinematic separation of product from target Compound nucleus recoil momentum is appreciable J. Alonso 12

Example: 82 Rb- 82 Sr Generator J. Alonso 13

Example: 82 Rb- 82 Sr Generator J. Alonso 14

Example: 82 Rb- 82 Sr Generator J. Alonso 15

75 As ( 11 B, 4n) 82 Rb Calculations using ALICE (Marshall Blann) J. Alonso 16

Yield of 82 Sr 75 As Target Thickness 25 mg/cm 2 Excitation function quite clean between 45 and 70 MeV From Northcliffe & Schilling, thickness of As to degrade boron from 70 to 45 25 mg/cm 2 Average cross section 950 millibarns Production rate.033 mci/µah Assume 100 pµa beam current Activity production of 82 Sr 3 millicuries/hour J. Alonso 17

139 La ( 12 C, 6n) 145 Eu 145 Eu: T 1/2 = 5.9 days, possible therapeutic agent Production rate: 0.3 mci/µah Activity production: 30 mci/hr J. Alonso 18

232 Th ( 13 C, 5n) 240 Cm 240 Cm: T 1/2 = 26.8 days, pure alpha emitter, excellent potential for therapeutic agent Production rate 2 µci/µahr Activity production: 0.2 mci/hr Note: (6n) 239 chain are short-lived β emitters J. Alonso 19

232 Th ( 14 N, 6n) 240 Bk 240 Cm Alternate production channel using 14 N 240 Bk (4.8 m T 1/2 ), no α branching, all β to 240 Cm 239 Bk (1.6 m T 1/2 ), both α and β chains shortlived Almost identical yield to 13 C Perhaps somewhat better purity J. Alonso 20

Kinematic Effects Projectile imparts substantial recoil momentum to compound nucleus E recoi l E projectile { m/(m+m)} For 82 Rb, E recoil 9.4 MeV = 0.11 MeV/amu Range of CN in 75 As 1.5 mg/cm 2 EG: If target irradiated is 1.5 mg/cm 2 thick, all products recoil out of target 0.7 mg/cm 2 He stop all recoils Flowing gas transports products to collection area Continuous production no hot-target chemistry J. Alonso 21

Composite Target Concept 1.5 mg/cm 2 target 0.7 mg/cm 2 helium 10 targets covers full excitation fcn 60% of maximum production rate 4 mci/hr No hot-target chemistry Continuous production At 8 atm, 0.7 mg/cm 2 He 5 mm J. Alonso 22

Comparing H - and Light Ions - Production rates with H - still substantially higher Lower proton de/dx allows thicker targets Initial design for RIA Driver current not optimized for maximum light-ion current + Light ion cross sections x10 higher + Thinner targets may allow more efficient cooling Yield may be determined by max current available, not by target engineering considerations + New isotopes available + More flexibility in target material selection + Kinematic effects may increase overall efficiency J. Alonso 23

Why is RIA Needed? Excitation functions, yields, chemistry, initial efficacy studies can all be done with isotopes produced at existing facilities (88, ATLAS, ) RIA is vital for next steps: Economics Development of technology for accelerator Low-risk replication of RIA Driver front end, at known cost Operating cost models Engineering Target development, thermal management Production, handling techniques J. Alonso 24

RIA Driver will be a Test Bed Enabling technology for reliable, high-current light-ion accelerator Development of engineering concepts for targets, material handling Validation of economic models for new medical isotope production Will lead to construction of dedicated production facilities J. Alonso 25

RIA could usher in a new age of accelerator-based medical isotope production J. Alonso 26